Skip to main content

Quest Diagnostics Value Stock - Dividend - Research Selection

Quest diagnostics

ISIN: US74834L1008 , WKN: 904533

Market price date:
Market price:  

Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Key figures
Cash flow
Balance sheet
Income statement
Div. Yield%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization USD
Raw Data Source
Stock Split

Description of the company

Quest Diagnostics Incorporated provides diagnostic testing information and services in the United States and internationally. The company\'s Diagnostic Information Services business segment develops and delivers diagnostic testing information and services, such as routine testing, non-routine and advanced clinical testing, gene-based and esoteric testing, anatomic pathology, and other diagnostic information services. This segment offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, Athena Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. Its Diagnostic Solutions segment offers risk assessment services for the life insurance industry; and health information technology solutions for healthcare organizations and clinicians. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,


Quest Diagnostics (DGX) Advances Transplant Testing Service

These services by Quest Diagnostics (DGX) are available to recipients and living donors across the United States (excluding Alaska and Hawaii), broadening access for both donor and patient.

Quest Diagnostics Inc. stock rises Thursday, outperforms market

Looking for stock market analysis and research with proves results? offers in-depth financial research with over 30years of proven results.

Quest Diagnostics Inc. stock falls Wednesday, still outperforms market

Shares of Quest Diagnostics Inc. shed 1.17% to $134.32 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P...

Sesame Workshop Launches New Resources for Parents, Caregivers, and Healthcare Providers Addressing Health and Well-Being Inequities, With Support From Quest Diagnostics

Sesame Workshop, the nonprofit educational organization behind Sesame Street, which reaches over 150 million children across more than 150 countries, today announced new resources addressing health and well-being inequities among young children, particularly in low-income, rural, and marginalized communities.

Quest Diagnostics Unveils Advanced Transplant Diagnostic Services Featuring Anywhere-Access in the United States

Quest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic information services, today unveiled a comprehensive suite of advanced diagnostics and support services designed to broaden access to laboratory tests for transplanting solid organ, human cells and tissue.

Quest Diagnostics Inc. stock outperforms competitors on strong trading day

Shares of Quest Diagnostics Inc. advanced 2.26% to $135.91 Tuesday, on what proved to be an all-around great trading session for the stock market, with the...

Quest Diagnostics (DGX) Acquires Northern Light Laboratory

Quest Diagnostics (DGX) now offers professional laboratory management services for nine of Northern Light Health's hospital laboratories.

First-of-Its-Kind Post-COVID-19 Panels Available at

The consumer-initiated testing business from the leader in diagnostic testing, Quest Diagnostics (NYSE: DGX), has introduced two innovative Post-COVID-19 panels. These laboratory tests are the only comprehensive tests currently available for consumers to purchase that offer information about lingering health issues associated with previous COVID-19 virus infections. These panels give consumers a deeper look into their health, helping to prepare them for meaningful discussions with their healthca

Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Quest Diagnostics Inc. stock rises Monday, outperforms market

Shares of Quest Diagnostics Inc. rallied 1.05% to $132.91 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P...